Teaching image-guided stereotactic methodology and functional neuroanatomy of the thalamus and pallidum: A simple ex vivo technique

1994 ◽  
Vol 8 (5) ◽  
pp. 579-583
Author(s):  
Ian R. Whittle ◽  
Michael O'sullivan ◽  
Robin Sellar ◽  
James Ironside
2019 ◽  
Vol 125 ◽  
pp. 198-206 ◽  
Author(s):  
Giacomo Bertolini ◽  
Emanuele La Corte ◽  
Domenico Aquino ◽  
Elena Greco ◽  
Zefferino Rossini ◽  
...  

2021 ◽  
Vol 7 (2) ◽  
pp. 105-108
Author(s):  
Thomas S. Rau ◽  
Jakob Cramer ◽  
M. Geraldine Zuniga ◽  
Georg Böttcher ◽  
Thomas Lenarz

Abstract Cochlear implants include an electrode array (EA) which needs to be inserted into the cochlea. Insertion tests using artificial cochlear models (ACM) or ex vivo specimens are widely used methods during EA development to characterize EA design properties, including insertion forces. Measured forces are directly linked to the orientation of the cochlear lumen with respect to the insertion axis of the test bench. While desired insertion directions in ACM experiments can be predefined by design, specimens are individually shaped and the cochlear lumen is embedded invisibly. Therefore, a new method for accurate, individual specimen positioning is required. A key element of the proposed method is a customizable pose setting adapter (PSA) used to adjust the specimen’s fine positioning. After rigid fixation of the specimen to a holder featuring spherical registration markers and subsequent cone beam computed tomography the desired insertion direction is planned. The planned data is used to calculate the individual shape of the PSA. Finally, the PSA is 3D printed and mounted between force sensor and specimen holder to correctly align the specimen to the test bench’s insertion axis. All necessary hard- and software have been developed including the specimen holder, a software for registration and trajectory planning, and a custom Matlab script whose output drives a parametric CAD file of the PSA. Positioning accuracy was determined in a first trial using 10 virtual trajectories and was found to be 0.23 ± 0.12 mm and 0.38 ± 0.17°. The presented stereotactic positioning procedure enables high repeatability in future ex vivo insertion experiments due to accurate, image-guided control of the insertion direction.


2015 ◽  
Vol 3 (S1) ◽  
Author(s):  
Christina Keravnou ◽  
Christophoros Mannaris ◽  
Maria-Louisa Izamis ◽  
Michalakis Averkiou
Keyword(s):  
Ex Vivo ◽  

2013 ◽  
Vol 29 (2) ◽  
pp. 188-195 ◽  
Author(s):  
Fernando Burdío ◽  
Enrique Berjano ◽  
Olga Millan ◽  
Luis Grande ◽  
Ignasi Poves ◽  
...  
Keyword(s):  
Ex Vivo ◽  

Sci ◽  
2021 ◽  
Vol 3 (1) ◽  
pp. 8
Author(s):  
Naama Lev-Cohain ◽  
Gal Sapir ◽  
Sivaranjan Uppala ◽  
Atara Nardi-Schreiber ◽  
Shraga Goldberg ◽  
...  

The clinical characterization of small hepatocellular carcinoma (HCC) lesions in the liver and differentiation from heterogeneous inflammatory or fibrotic background is important for early detection and treatment. Metabolic monitoring of hyperpolarized 13C-labeled substrates has been suggested as a new avenue for diagnostic magnetic resonance. The metabolism of hyperpolarized [1-13C]pyruvate was monitored in mouse precision-cut liver slices (PCLS) of aged MDR2-KO mice, which served as a model for heterogeneous liver and HCC that develops similarly to the human disease. The relative in-cell activities of lactate dehydrogenase (LDH) to alanine transaminase (ALT) were found to be 0.40 ± 0.06 (n = 3) in healthy livers (from healthy mice), 0.90 ± 0.27 (n = 3) in heterogeneously inflamed liver, and 1.84 ± 0.46 (n = 3) in HCC. Thus, the in-cell LDH/ALT activities ratio was found to correlate with the progression of the disease. The results suggest that the LDH/ALT activities ratio may be useful in the assessment of liver disease. Because the technology used here is translational to both small liver samples that may be obtained from image-guided biopsy (i.e., ex vivo investigation) and to the intact liver (i.e., in a noninvasive MRI scan), these results may provide a path for differentiating heterogeneous liver from HCC in human subjects.


2007 ◽  
Author(s):  
Jerry Bieszczad ◽  
Eric Friets ◽  
Darin Knaus ◽  
Thomas Rauth ◽  
Alan Herline ◽  
...  

Sci ◽  
2020 ◽  
Vol 2 (2) ◽  
pp. 43
Author(s):  
Naama Lev-Cohain ◽  
Gal Sapir ◽  
Sivaranjan Uppala ◽  
Atara Nardi-Schreiber ◽  
Shraga Nahum Goldberg ◽  
...  

The clinical characterization of small hepatocellular carcinoma (HCC) lesions in the liver and differentiation from heterogeneous inflammatory or fibrotic background is important for early detection and treatment. Metabolic monitoring of hyperpolarized 13C-labeled substrates has been suggested as a new avenue for diagnostic magnetic resonance. The metabolism of hyperpolarized [1-13C]pyruvate was monitored in mouse precision-cut liver slices (PCLS) of aged MDR2-KO mice, which served as a model for heterogeneous liver and HCC that develops similarly to the human disease. The relative in-cell activities of lactate dehydrogenase (LDH) to alanine transaminase (ALT) were found to be 0.40 ± 0.06 (n = 3) in healthy livers (from healthy mice), 0.90 ± 0.27 (n = 3) in heterogeneously inflamed liver, and 1.84 ± 0.46 (n = 3) in HCC. Thus, the in-cell LDH/ALT activities ratio was found to correlate with the progression of the disease. The results suggest that the LDH/ALT activities ratio may be useful in the assessment of liver disease. Because the technology used here is translational to both small liver samples that may be obtained from image-guided biopsy (i.e., ex vivo investigation) and to the intact liver (i.e., in a non-invasive MRI scan), these results may provide a path for differentiating heterogeneous liver from HCC in human subjects.


2005 ◽  
Vol 47 (2) ◽  
pp. 310-317 ◽  
Author(s):  
Frederick L. Ruberg ◽  
Jason Viereck ◽  
Alkystis Phinikaridou ◽  
Ye Qiao ◽  
Joseph Loscalzo ◽  
...  

2016 ◽  
Vol 28 (01) ◽  
pp. 1650003
Author(s):  
Cheng Li ◽  
Jin Yao Teo ◽  
Jiaze Wu ◽  
Apoorva Gogna ◽  
Bien Soo Tan ◽  
...  

Testing objects are important for the validation of developing biopsy systems. Unfortunately, they are very hard to obtain. Motivated by this issue, the purpose of this study is to develop a technique for the easy creation of a model to simulate tumors of different sizes inside porcine livers, which could be used for ultrasound image-guided liver biopsy amongst other applications, and evaluate its performance by comparing to the more widely-used approaches in-vivo and ex-vivo. In this study, a Vaseline-based tumor model, and a more widely-used agar-based tumor model to provide comparison with the proposed method were created and injected into porcine livers as biopsy targets. The clinician located simulated tumors using real-time 2D imaging under the guidance of a robotic arm to delivery the biopsy in ex-vivo and in-vivo experiments. The results show that the optimum tumor model was created from a mixture of Vaseline, glycerol, and barium sulfate which can be easily produced and injected. All Vaseline-based simulated tumors were of solid, palpable mass on gross examination, and ultrasound imaging revealed clearly visible lesions. The clinician successfully performed ultrasound image guided liver biopsy in all the trials (10/10) in the ex-vivo experiment, and 2 out of 3 trials (2/3) in the in-vivo experiment on this optimum tumor model. We described a novel technique of creating solid liver tumor models that can be used for ultrasound image-guided liver biopsy.


Sign in / Sign up

Export Citation Format

Share Document